explore -WSS

explore

author：entertainment 2025-09-30 12:11:07 - browse：16

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Lawsuit alleges UnitedHealth Group unit illegally denied claims

WSS

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Americans' trust in science, scientist continues decline: Report

Radiology is caught between AI's potential and concern for patients

Physician groups backed by private equity giant lobby on mergers

In diabetes hearing, Sanders takes on a new foe: food makers

New safety details link Apellis eye drug to rare cases of blindness

leisure time

explore

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

FDA needs staff influx to meet gene therapy needs, Marks says

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Psychedelics group wrestles with new pharma identity

Pregnancy discrimination could be enabled by AI

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Mega Millions pot grows to $1.25 billion after no winner

Bright Health sells Medicare Advantage business to Molina

Why sickle cell disease is getting the first CRISPR treatment

entertainment

No plane should take off without an EpiPen onboard

NIH launches clinical trials and new research office for long Covid

Adults seen as increasingly susceptible to measles

SCOTUS to consider access to abortion pill mifepristone

Teach medical students about patients with intellectual disabilities

After sickle

hotspot

focus

focus

Wikipedia